PARK2 and PARK7 Gene Polymorphisms as Risk Factors Associated with Serum Element Concentrations and Clinical Symptoms of Parkinson’s Disease
Published in General & Internal Medicine
In summary, the effects of genetic polymorphisms of the PARK2 and PARK7 genes on serum trace elements are investigated in a large cohort of the Indian population. We have noticed a significant influence of the PARK2 and PARK7 polymorphisms on serum elements’ homeostasis of Cu, Fe and Zn in PD. Further analyses of genotypes and element concentrations with clinical variables showed a significant relationship with the neuropsychiatric symptoms of PD. Taken together, our results demonstrate the genotype-dependent effect on the serum concentrations and clinical symptoms. This is a rare study in the area of neurology to investigate the influence of genetic polymorphisms on serum trace elements; therefore, it is difficult to compare our results with other data in the literature. Hence, our results needed to be interpreted with caution. However, the combined association of gene polymorphisms and serum trace elements in PD risk remains unexplored. Researches in this perspective are currently required to understand the biological mechanisms relating to genetic variants and trace elements.